Paid Clinical Trials Springfield

Discover 38 paid clinical trials in Springfield, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 38

LumateperoneMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Recruiting

PHASE3

Sponsor:

Intra-Cellular Therapies, Inc.

Location:

St. Charles MO, Saint Charles MO, Oklahoma City OK, Lincoln NEshow 38 more

Code:

NCT06372964

Conditions

Bipolar Depression

Eligibility Criteria

Sex: All

Age: 10 - 17

Healthy Volunteers: Not accepted

Interventions

Lumateperone

Placebo

Alisertib & Endocrine TherapyA Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

Recruiting

PHASE2

Sponsor:

Puma Biotechnology, Inc.

Location:

Springfield MO, Kansas City MO, Saint Louis MO, Dallas TXshow 18 more

Code:

NCT06369285

Conditions

Hormone Receptor Positive HER-2 Negative Breast Cancer

Metastatic Breast Cancer

Recurrent Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Alisertib

Endocrine therapy

Ventral IncisionProphylactic Reinforcement of Ventral Abdominal Incisions Trial

Recruiting

Sponsor:

C. R. Bard

Location:

Springfield MO, Kansas City MO, Memphis TN, Peoria ILshow 22 more

Code:

NCT03911700

Conditions

Open Midline Laparotomy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Phasix™ Mesh

Biobank RegistryTEMPUS ARIES: A Biobank Registry Platform Study in Oncology

Recruiting

Sponsor:

Tempus AI

Location:

Springfield MO, Osage Beach MO, O'Fallon IL, Carterville ILshow 20 more

Code:

NCT06207032

Conditions

Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Amivantamab & DocetaxelA Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung Cancer

Recruiting

PHASE1

PHASE2

Sponsor:

Janssen Research & Development, LLC

Location:

Springfield MO, Fairfax VA, Flemington NJ, Orange CAshow 2 more

Code:

NCT06532032

Conditions

Carcinoma, Non-Small-Cell Lung

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Amivantamab

Docetaxel

DupilumabEvaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)

Recruiting

PHASE2

Sponsor:

Andover Eye Associates

Location:

Springfield MO, Pittsburg KS, Kansas City MO, Town And Country MOshow 16 more

Code:

NCT04296864

Conditions

Atopic Keratoconjunctivitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dupilumab

Tissue BankingProtocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility

Recruiting

Sponsor:

St. Jude Children's Research Hospital

Location:

Springfield MO, Tulsa OK, Memphis TN, Peoria ILshow 9 more

Code:

NCT01354002

Conditions

Normal and Diseased Tissue and Body Fluids Samples

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Accepted

LY3537031A Study of LY3537031 in Overweight, Obese, and Healthy Participants

Recruiting

PHASE1

Sponsor:

Eli Lilly and Company

Location:

Springfield MO, Dallas TX, Daytona Beach FL, Miami FLshow 1 more

Code:

NCT06606106

Conditions

Healthy

Obesity

Eligibility Criteria

Sex: All

Age: 22 - 65

Healthy Volunteers: Accepted

Interventions

LY3537031

Placebo

Observational StudyImpact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Springfield MO, Oklahoma City OK, Omaha NE, Richardson TXshow 32 more

Code:

NCT05646316

Conditions

Stage I Uterine Corpus Cancer AJCC v8

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Diagnostic Imaging

Excisional Biopsy

Indocyanine Green Solution

Minimally Invasive Surgery

Tarlatamab & DurvalumabStudy Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab

Recruiting

PHASE3

Sponsor:

Amgen

Location:

Springfield MO, Memphis TN, Omaha NE, Dallas TXshow 33 more

Code:

NCT06211036

Conditions

Extensive-Stage Small-Cell Lung Cancer

Small-Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Tarlatamab

Durvalumab